JAZZ Financial Facts
Total operating expenses: 237.93MIntangible asset amortization: 26.45M
See Full Income Statement
See Full Balance Sheet
Jazz Pharmaceuticals, Inc. (JAZZ) Earnings
|
Expand Research on JAZZ
| Next EPS Date | 8/5/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -8.1% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | $4.55 | N/A | N/A | $974.91M | N/A | N/A | N/A | ||
| 2/24/26 | Q425 | $6.64 | $6.39 | +$0.25 | $1.2B | $1.16B | N/A |  | | Details | |
| 11/5/25 | Q325 | $8.13 | $5.93 | +$2.20 | $1.13B | $1.11B | = | | | Details | |
| 8/5/25 | Q225 | -$8.25 | -$7.62 | -$0.63 | $1.05B | $1.04B | = | | | Details | |
| 5/6/25 | Q125 | $1.68 | $4.81 | -$3.13 | $897.84M | $983.86M | = | | | Details | |
| 2/25/25 | Q424 | $6.60 | $5.79 | +$0.81 | $1.1B | $1.06B | = | | | Details | |
| 11/6/24 | Q324 | $6.61 | $5.50 | +$1.11 | $1.06B | $1.04B | = | | | Details | |
| 7/31/24 | Q224 | $5.30 | $4.77 | +$0.53 | $1.02B | $1B | = | | | Details |
